# To Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Multiple Sclerosis Patients

> **NCT01080040** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 150 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing Remitting

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01080040
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2013-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01080040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01080040, "To Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01080040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*